Back to search
FDAFDA · Food and drugs·Recall number D-1566-2020

Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.

Published September 16, 2020 · Recall initiated: August 24, 2020

Summary

FDA records drug Class II recall D-1566-2020, published September 16, 2020 and initiated August 24, 2020. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 38,487 bottles; Lot: Lot #: 30310638A, Exp. 02/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sub-Potent Drug: Out of specification test results for potency (below specification).

What to do

Voluntary: Firm initiated · Letter

Get an email if CEPHALEXIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CEPHALEXIN
Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide in the U.S. and Puerto Rico.
UPC
0300934175738
Lot
Lot #: 30310638A, Exp. 02/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73. recalled?

Yes. FDA published recall D-1566-2020 on September 16, 2020. Reported hazard: Sub-Potent Drug: Out of specification test results for potency (below specification).

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CEPHALEXIN. UPC: 0300934175738.